Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
67 hedge funds and large institutions have $9.53M invested in Avid Bioservices, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 3 closing their positions.
300% more call options, than puts
Call options by funds: $12K | Put options by funds: $3K
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
2% more funds holding
Funds holding: 66 → 67 (+1)
30% less capital invested
Capital invested by funds: $13.7M → $9.53M (-$4.15M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$157K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$51.7K |
| 3 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$51K |
| 4 |
Morgan Stanley
New York
|
+$30.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.3M |
| 2 |
D.E. Shaw & Co
New York
|
-$275K |
| 3 |
Millennium Management
New York
|
-$221K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$151K |
| 5 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$104K |
CDMO Hedge Fund Activity: Q4 2016 in Review
67 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2016, worth a combined $9.53M — down 30% from $13.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CDMO positions and 3 closed out — a net gain of 3 holders — while 21 added to existing stakes and 14 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $157K. The largest seller was Vanguard Group, cutting an estimated $1.3M.
- 67 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2016, up from 66 in Q3 2016.
- Funds reported $9.53M of Avid Bioservices, Inc. Common Stock stock for Q4 2016, down 30% quarter-over-quarter.
- 6 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2016 and 3 closed out, a net change of +3 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2016 was Squarepoint, an estimated $157K added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2016 was Vanguard Group, an estimated $1.3M sold.
Based on aggregated 13F filings for Q4 2016.